🔎 Trials Near Me

Utama › Jangkitan Virus › New York

Kajian klinikal Jangkitan Virus di New York

6 kajian untuk Jangkitan Virus sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Buffalo
  • Research Site, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

  • NYC Health + Hospitals/Lincoln Medical Center - BRANY - PPDS, The Bronx
  • Prime Global Research, Inc., The Bronx
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07214571

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Upstate Global Health Institute, East Syracuse
  • Upstate Connect Care, Syracuse
  • Prime Global Research, The Bronx
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

  • NYU Langone Health, New York
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07654283

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

  • New York Medical College, Vallhala
Mengambil pesertaFasa 1/2
1 Month – 79 Years · Semua jantina · Dikemas kini 15 Apr 2026 · NCT04197596

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients

  • Montefiore Medical Center, New York
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jan 2026 · NCT07110636

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.